AKT1 and acute myeloid leukemia: Reversion of signaling by inhibition of PI3K or AKT has been shown to result in the redistribution of Foxo3a from the cytoplasm to the nucleus in numerous models, but this was not observed in a study [69] involving primary AML human samples and a leukemic cell line.